Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer

A team of clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS), Agency for Science, Technology and Research (A*STAR), the Harry Perkins Institute of Medical Research and global research partners, has found a causal link between the presence of oncofetal ecosystems (re-emergence of fetal programme/features driven by the tumor) in the primary liver cancer hepatocellular carcinoma (HCC) and cancer recurrence and response to immunotherapy.

Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients

Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.

October 20, 2023

More than half the slots on a key vaccine advisory panel are vacant. Where’s HHS?

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in

February 8, 2024

MarketingRx roundup: Pfizer reups baby checkup campaign on socials; BI, Takeda on top employers list

Pfizer is reminding parents again that “Baby Checkups Count” with new social media ads and recent sponsored influencer posts, rebooting its ongoing effort that first

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.